
VEXAS syndrome is a newly described adult-onset autoinflammatory disorder, predominantly affecting males (median age, 68), and recognized by somatic mutations in the UBA1 gene in blood-forming cells of the X chromosome. This rare disease causes systemic inflammation and abnormalities in the blood, with high morbidity and mortality when untreated.
VEXAS syndrome has been defined by mutations in the UBA1 gene and represents a rare but life-threatening condition affecting mainly men over the age of 50. Thus, early diagnosis of VEXAS is critical, since there is no prevention, and it probably has an overlap with other inflammatory conditions concerning signs and symptoms. Making the diagnosis early on may ease symptoms and ultimately prolong survival with timely diagnosis, appropriate treatment with steroids or immunosuppressants, or definitive therapy with a continued option of allogeneic bone marrow transplant. This is the most exciting area of research with new therapies, so education about this condition and timely interventions for at-risk patients is paramount.
Disclaimer- This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a healthcare provider for diagnosis or treatment of any medical condition.
Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up
Oct 16 (Reuters) - The weight-loss drug market is booming, with biotech firms racing to…
Sungjae Im takes control of Macao Open
VIDEO SHOWS: HIGHLIGHTS FROM ROUND TWO OF THE ASIAN TOUR'S MACAO OPEN COMPLETE SHOTLIST AND…
UPDATES THROUGHOUT THE STATE DEPARTMENT DAYBOOK Friday, October 16, 2026 ----- The daybook editor is…